[CLDX] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 31.67%
YoY- 28.21%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 163 3,480 236 715 2,763 3,829 1,389 -30.01%
PBT -36,004 -13,373 -11,259 -11,779 -16,407 -28,566 -31,952 2.00%
Tax 16,564 382 -228 -2,990 -15,798 1,276 -828 -
NP -52,568 -13,373 -11,031 -11,779 -16,407 -28,566 -31,952 8.64%
Tax Rate - - - - - - - -
Total Cost 52,731 16,853 11,267 12,494 19,170 32,395 33,341 7.93%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -32,250.31 -384.28 -4,674.15 -1,647.41 -593.81 -746.04 -2,300.36 55.25%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -1.12 -0.34 -0.50 -0.84 -1.67 -3.42 -4.85 -21.66%
EPS Diluted -1.12 -0.34 -0.50 -0.84 -1.67 -3.42 -4.85 -21.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.